210 related articles for article (PubMed ID: 21829568)
1. The X-linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway.
Kido T; Ou JH; Lau YF
PLoS One; 2011; 6(7):e22979. PubMed ID: 21829568
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus X Protein Is Stabilized by the Deubiquitinating Enzyme VCPIP1 in a Ubiquitin-Independent Manner by Recruiting the 26S Proteasome Subunit PSMC3.
Wu Q; Zhang L; Xu X; Zhang Y; Shi J; Lin X; Chen W
J Virol; 2022 Jul; 96(13):e0061122. PubMed ID: 35695579
[TBL] [Abstract][Full Text] [Related]
3. E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein.
Zhao J; Wang C; Wang J; Yang X; Diao N; Li Q; Wang W; Xian L; Fang Z; Yu L
FEBS Lett; 2011 Oct; 585(19):2943-50. PubMed ID: 21878328
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
[TBL] [Abstract][Full Text] [Related]
5. The potential contributions of a Y-located protooncogene and its X homologue in sexual dimorphisms in hepatocellular carcinoma.
Kido T; Lo RC; Li Y; Lee J; Tabatabai ZL; Ng IO; Lau YF
Hum Pathol; 2014 Sep; 45(9):1847-58. PubMed ID: 25017435
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
[TBL] [Abstract][Full Text] [Related]
7. Tumor Suppressor p53 Inhibits Hepatitis B Virus Replication by Downregulating HBx via E6AP-Mediated Proteasomal Degradation in Human Hepatocellular Carcinoma Cell Lines.
Lim HY; Han J; Yoon H; Jang KL
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298868
[TBL] [Abstract][Full Text] [Related]
8. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
9. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
[TBL] [Abstract][Full Text] [Related]
10. Chromatin remodelling factor BAF155 protects hepatitis B virus X protein (HBx) from ubiquitin-independent proteasomal degradation.
Chen H; Zhang Y; Ye S; Wu Q; Lin Y; Sheng K; Chen W; Lin X; Lin X
Emerg Microbes Infect; 2019; 8(1):1393-1405. PubMed ID: 31533543
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-κB, 5-LOX, OPN and Capn4 to promote cell migration.
Zhang X; You X; Wang Q; Zhang T; Du Y; Lv N; Zhang Z; Zhang S; Shan C; Ye L; Zhang X
PLoS One; 2012; 7(2):e31458. PubMed ID: 22355367
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
13. HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma.
Zhao Z; Hu Y; Shen X; Lao Y; Zhang L; Qiu X; Hu J; Gong P; Cui H; Lu S; Zheng Y; Zhou M; Fan H
Oncol Rep; 2017 May; 37(5):2811-2818. PubMed ID: 28339081
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.
Fan H; Zhang H; Pascuzzi PE; Andrisani O
Oncogene; 2016 Feb; 35(6):715-26. PubMed ID: 25893293
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.
Huang Y; Tong S; Tai AW; Hussain M; Lok AS
Gastroenterology; 2011 Oct; 141(4):1412-21, 1421.e1-5. PubMed ID: 21704589
[TBL] [Abstract][Full Text] [Related]
16. Proteasomal activator 28 gamma stabilizes hepatitis B virus X protein by competitively inhibiting the Siah-1-mediated proteasomal degradation.
Han J; Kim H; Jeong H; Yoon H; Jang KL
Biochem Biophys Res Commun; 2021 Nov; 578():97-103. PubMed ID: 34555669
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro.
Wu G; Yu F; Xiao Z; Xu K; Xu J; Tang W; Wang J; Song E
Br J Cancer; 2011 Jun; 105(1):146-53. PubMed ID: 21629246
[TBL] [Abstract][Full Text] [Related]
18. RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function.
Lim KH; Kim KH; Choi SI; Park ES; Park SH; Ryu K; Park YK; Kwon SY; Yang SI; Lee HC; Sung IK; Seong BL
PLoS One; 2011; 6(8):e22258. PubMed ID: 21857917
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
Kim HY; Jung HU; Yoo SH; Yoo KS; Cheong J; Park BS; Yun I; Yoo YH
Cancer Lett; 2014 Dec; 355(1):61-9. PubMed ID: 25218348
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression.
Lim JH; Kim DG; Yu DY; Kang HM; Noh KH; Kim DS; Park D; Chang TK; Im DS; Jung CR
Cell Mol Life Sci; 2019 Jul; 76(13):2647-2662. PubMed ID: 30903204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
